A new treatment offers hope for fighting cancer.
Sharon Belvin’s nightmare with cancer began in 2004, when she was just 22.
Belvin was an avid runner but said she suddenly found she couldn’t climb the stairs without “a lot of difficulty breathing.”
Eventually, after months of fruitless treatments for lung ailments like bronchitis, she was diagnosed with melanoma — a very serious skin cancer. It had already spread to her lungs, and the prognosis was grim. She had about a 50-50 chance of surviving the next six months.
“Yeah, that was the turning point of life, right there,” she says.
What Belvin didn’t know at the time was that a revolutionary treatment for melanoma had begun testing in clinical trials. An immunologist named Jim Allison, now at the University of Texas MD Anderson Cancer Center, had figured out that if the immune system was tweaked just right, it could do a better job of killing the cancer than the usual treatments. (Joe Palca worked for Allison early in both men’s careers.)
Allison’s treatment was still experimental, but if it worked, it had the potential to save Belvin’s life.
Read Full Article: Immunotherapy Becomes Reality For Cancer : Shots – Health News : NPR
|Read Full Article: Immunotherapy Becomes Reality For Cancer : Shots – Health News : NPR|